OncLive® On Air
/
CRC Experts Highlight AE Management and Prevention Strategies for TAS-102/Bevacizumab, Regorafenib, and Fruquintinib
Our original embed player - you can use this to maintain continuity with any other episodes you've already embedded. Otherwise we'd suggest
upgrading to our new player.